Orlando Regional Medical Center Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2012
NCT01513759
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Orlando Regional Medical Center

Active Ingredients

Drugs in Phase 3 Trials (1)

alteplase (Activase) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Embolism (Phase 3)

Pulmonary Embolism (Phase 3)

Thromboembolism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1